T-Cypher Bio
Biotechnology Research • 
Oxford, England, United Kingdom • 21-50 Employees
Company overview
| Headquarters | Oxford, England, United Kingdom |
| Website | |
| NAICS | 541714 |
| Founded | 2021 |
| Employees | 21-50 |
| Socials |
Key Contacts at T-Cypher Bio
Thomas L. Andresen
Chief Executive Officer
Daniel Perez Witzke
Director Of Antibody Platform Development
Eleanor Bagg
Associate Director
Peter Cain
Director, Head Of Protein Engineering
Hemza Ghadbane
Senior Director
Joanne Oates
Senior Director, Ip
Nathaniel Davies
Senior Director Computational Biology
Dominic Hine
Associate Director
T-Cypher Bio Email Formats
T-Cypher Bio uses 4 email formats. The most common is {first initial} (e.g., j@tcypherbio.com), used 52.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@tcypherbio.com | 52.6% |
{first name}{last name} | johndoe@tcypherbio.com | 28.9% |
{first initial}{last name} | jdoe@tcypherbio.com | 13.2% |
{first name} | john@tcypherbio.com | 5.3% |
About T-Cypher Bio
At T-Cypher Bio we generate novel TCR-based therapeutics that have the potential to transform the treatment of immune-mediated disease. Our proprietary platforms provide unique insight into T cell based immunity in both health and disease. High throughput, high-resolution profiling of the immune synapse enables us to map the intracellular target space and profile T cell specificity. These platforms not only give us tools to build highly innovative drugs, but also build immune system data sets of unprecedented size. These data sets support cutting edge computational modelling of T cell repertoires which will revolutionize T cell immunology. To build our oncology pipeline, we validate novel, shared, tumour-specific targets and identify panels of rare functionally-defined T cell clones. The unique TCRs we identify are the foundation of our broad pipeline of lifesaving therapeutics for underserved solid tumour patients.
T-Cypher Bio revenue & valuation
| Annual revenue | $3,593,310 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $11,500,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
T-Cypher Bio has 13 employees across 8 departments.
Departments
Number of employees
T-Cypher Bio Tech Stack
Discover the technologies and tools that power T-Cypher Bio's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Web servers
Hosting
Recruitment & staffing
Miscellaneous
Programming languages
Miscellaneous
Security
A/B Testing
Blogs
Miscellaneous
Ireland
Canada
United States
Frequently asked questions
4.8
40,000 users
